arrow
Back
R

Razelle Kurzrock

medical college of wisconsin

144H-index
2.3KPaper Count
8.7WCitation Count
Published Papers 535
Publication Date
Immunotherapy Efficacy in SMARC-Altered Cancers: A pan-cancer analysis of clinical outcomes in response to immune checkpoint inhibition
err2026-08-06
err0
errOAAI
errGregory P. Botta; Wesleigh Edwards; Daisuke Nishizaki; Diana C. Hargreaves; Shumei Kato; Razelle Kurzrock
errShare
errSave
A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort
err2026-07-23
err0
PREAI
errYoung Kwang Chae; Rosie Sun; Sandip P. Patel; Francis Giles; James P. Ohr; Francis P. Worden; Jennifer M. Suga; Aung Naing; Ezra E. Cohen; James Wallace; Hyun Seok Kang; Sarah Fenton; Liam Il-Young Chung; Christine M. McLeod; Helen X. Chen; Elad Sharon; Howard Streicher; Christopher W. Ryan; Megan Othus; Charles D. Blanke; Razelle Kurzrock
errShare
errSave
OX40 transcriptomic expression and its association with immune checkpoints and clinical outcomes
err2026-07-12
err0
PREAI
errBicky Thapa; Daisuke Nishizaki; Hirotaka Miyashita; Suzanna Lee; Mary K. Nesline; Rebecca A. Previs; Jeffrey M. Conroy; Taylor J. Jensen; Paul DePietro; Sarabjot Pabla; Shumei Kato; Razelle Kurzrock
errShare
errSave
ERBB2/HER2 landscape and prognostic impact: large-scale, real-world analysis across solid cancers
err2026-06-15
err0
errOAAI
errA. Shreenivas; A. Elliott; T. Corbiere; H.-Z. Chen; B. George; M. Kamgar; S. Chakrabarti; A. Desai; D. Bracken-Clarke; E. Xue; C.S. Floudas; J. Thomas; J. Xiu; G. Sledge; E.S. Antonarakis; Y. Boumber; R. Kurzrock
errShare
errSave
Interleukin-2 transcriptomic expression correlates with prolonged survival and with GNAS alterations in patients with advanced cancers
err2026-06-09
err0
errOAAI
errJ. Ahmed; D. Nishizaki; Y. Fujiwara; P. DePietro; T.J. Jensen; T. McFall; S. Kato; R. Kurzrock
errShare
errSave
Context-Dependent Survival Associations Between Interleukin-13 Expression and Immunotherapy in Advanced Solid Tumors
err2026-05-04
err0
errOAAI
errElena Fountzilas; Razelle Kurzrock; Daisuke Nishizaki; Aniko Szabo; Sarabjot Pabla; Paul DePietro; Taylor J Jensen; Shumei Kato; Apostolia-Maria Tsimberidou
errShare
errSave
DART (NCI/SWOG S1609): Comprehensive Final Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare Cancers
err2026-04-15
err0
PREAI
errS.P. Patel; M. Othus; Y.K. Chae; T. Azenkot; C. Alviz; S. Threlkel; C. Haymaker; H.Z. Streicher; C.M. Magner; H.X. Chen; E. Sharon; C.W. Ryan; C.D. Blanke; R. Kurzrock
errShare
errSave
errShare
errSave
Precision oncology in rare tumors: Have the orphans been adopted?
errMed
IF11.8
err2026-01-28
err0
errOAAI
errHiba Mechahougui; Alex Friedlaender; Kıvanç Görgülü; Petros Tsantoulis; Anna Lena Illert; Vivek Subbiah; Adam Wahida; Razelle Kurzrock
errShare
errSave
errShare
errSave
CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonists
err2025-11-03
err0
errOAAI
errYuji Uehara; Daisuke Nishizaki; Yu Fujiwara; Hirotaka Miyashita; Suzanna Lee; Sarabjot Pabla; Paul DePietro; Heidi Ko; Taylor J. Jensen; Jason K. Sicklick; Shumei Kato; Razelle Kurzrock
errShare
errSave
The Expendables: Overlooked Medications with Anti-Cancer Properties
err2025-11-01
err0
PREAI
errAnagha J. Deshpande; Javier Munoz; Razelle Kurzrock
errShare
errSave
B7-H3/CD276: Novel Immune Checkpoint and Jack of All Trades
err2025-09-05
err0
errOAAI
errBrigid Larkin; Daisuke Nishizaki; Hirotaka Miyashita; Suzanna Lee; Mina Nikanjam; Ramez N Eskander; Taylor J Jensen; Sarabjot Pabla; Jeffrey M Conroy; Paul DePietro; Jason K Sicklick; Razelle Kurzrock; Shumei Kato
errShare
errSave
OncoAID: an open access targeted anti-cancer drugs database
err2025-08-13
err0
errOAAI
errOhad Landau; Shai Magidi; Catherine Bresson; Fanny Wunder; Razelle Kurzrock; Wafik S. El-Deiry; Kartheeswaran Thangathurai†; Eitan Rubin
errShare
errSave
Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection
err2025-07-24
err0
errOAAI
errDaisuke Nishizaki; Razelle Kurzrock; Jacob J. Adashek; Ki Hwan Kim; Hyo Jeong Lim; Mina Nikanjam; Ramez N. Eskander; Paul T. Fanta; Ryosuke Okamura; Suzanna Lee; Jason K. Sicklick; Scott M. Lippman; Shumei Kato
errShare
errSave
Mucin-1: a promising pan-cancer therapeutic target
err2025-07-02
err0
errOAAI
errUdhayvir Singh Grewal; Razelle Kurzrock
errShare
errSave
Ag(e)nostic precision oncology therapy approvals across the years
err2025-06-05
err0
errOAAI
errMatthew R. Kudek; Jacob J. Adashek; Razelle Kurzrock
errShare
errSave
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort
err2025-05-22
err0
errOAAI
errYoung Kwang Chae; Megan Othus; Sandip Pravin Patel; Raid Aljumaily; Khine Z. Win; Tanya Pejovic; Sajeve S. Thomas; William R. Robinson III; Hye Sung Kim; Liam Il-Young Chung; Christine M. McLeod; Helen X. Chen; Elad Sharon; Howard Streicher; Christopher W. Ryan; Charles D. Blanke; Razelle Kurzrock
errShare
errSave
Real-world characteristics and survival outcomes of patients with metastatic ALK fusion-positive solid tumors treated with standard-of-care therapies
err2025-05-08
err0
errOAAI
errGadgeel, Shirish M.; Fajardo, Otto; Barlesi, Fabrice; Kim, Jeong Eun; Kurzrock, Razelle; Thomas, David M.; Jagtiani, Ritika; Noe, Johannes; Schwemmers, Sven; Nikolaidis, Christos
errShare
errSave